Ultrasound Diaphragmatic Thickening to Monitor Its Dysfunction in Patients With Sepsis
US-Diamonds
Assessment of Diaphragmatic Function by Ultrasonographic Measure of Diaphragmatic Thickening in Severe Sepsis or Septic Shock Patients Hospitalized in ICU: Diaphragmatic Dysfunction Frequency, Prognosis Values and Associated Factors
1 other identifier
interventional
50
1 country
1
Brief Summary
Diaphragmatic dysfunction is associated with sepsis severity and pejorative prognosis. Aim of this study is to assess diaphragmatic function with the Diaphragmatic Thickening Fraction (DTF) ultrasound measure in patients with severe sepsis or septic shock, mechanically ventilated or not, hospitalized in ICU in order to determinate diaphragmatic dysfunction frequency, its prognosis value and its associated factors. This is a prospective pilot study in a 14-bed medical and surgical ICU including 50 consecutive patients with severe sepsis or septic shock. The expected duration of study is 18 months. DTF is measured each day as follow: the probe is placed in an intercostal space between mid axillary line and anterior axillary line, 0.5cm to 2 centimeters below the costodiaphragmatic sinus. DTF measure is performed in B-mode using the following formula: TF (%) = \[(end-inspiration thickness - end-expiration thickness)/(end-expiration thickness) x 100\]. A DTF \< 20% indicates a diaphragmatic dysfunction. The investigators will collect potential factors for which DTF Ultrasound Measure could have a prognosis value (intubation, successful or failed weaning from mechanical ventilation), potential risk factors (age, sex, tobacco, alcohol etc.) and potentials associated factors. The investigators expect measure of DTF allows identifying patient with severe sepsis or septic shock with diaphragmatic dysfunction. It would also estimate diaphragmatic dysfunction frequency with ultrasound measure and warranting its use routinely at the bedside. The investigators expect that DTF helps to characterize degree of severity of septic patient and can be a new index able to predict intubation in this population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable sepsis
Started May 2015
Longer than P75 for not_applicable sepsis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 4, 2015
CompletedFirst Submitted
Initial submission to the registry
June 3, 2015
CompletedFirst Posted
Study publicly available on registry
June 18, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 8, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2020
CompletedMay 1, 2020
April 1, 2020
4.2 years
June 3, 2015
April 30, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diaphragmatic Dysfunction with DTF Ultrasound measure
Diaphragmatic dysfunction is defined by DTF \< 20%. Frequency of diaphragmatic dysfunction is measured by the ratio of: number of patient with DTF \< 20% during ICU hospitalization on total number of patients included.
Participants will be followed for the duration of ICU stay, an expected average of 10 days
Secondary Outcomes (4)
Collection of potential factors for which DTF Ultrasound Measure could have a prognosis value: intubation, successful or failed weaning from mechanical ventilation
Participants will be followed for the duration of ICU stay, an expected average of 10 days
Collection of potential risk factors: age, sex, tobacco, alcohol, cirrhosis, diabetes mellitus
At baseline
Collection of potentials associated factors: medication (hypnotics, opioids, steroids, catecholamines), mechanical ventilation, presence of a septic shock, severity score (SOFA), ICU and Hospital Length of stay, ICU and Hospital mortality
Participants will be followed for the duration of ICU stay, an expected average of 10 days
Change in Diaphragmatic Thickening Fraction with DTF Ultrasound measure
Participants will be followed for the duration of ICU stay, an expected average of 10 days
Study Arms (1)
Diaphragmatic ultrasonography in septic patient
EXPERIMENTALDiaphragmatic Thickening Fraction
Interventions
Daily Measure of Diaphragmatic Thickening Fraction (DTF) will be performed by a trained physiotherapist. Physiotherapist (A. LE NEINDRE). The patient will be then instructed to perform breathing to total lung capacity and then to exhale to residual volume, when it is possible (awaken patient). Awakening status will be recorded. Mechanically ventilated patients will be evaluated in Pressure Support (PS) mode (during daily PS mode research for patients with Controlled Ventilation), with the lower PS level tolerated. PS level will be recorded. Thickening fraction (TF) measure is performed in B-mode using the following formula: TF (%) = \[(end-inspiration thickness - end-expiration thickness)/(end-expiration thickness) x 100\]. Diaphragmatic dysfunction is defined like a DTF \< 20% (7).
Eligibility Criteria
You may qualify if:
- Patient hospitalized in our Medical/Surgical ICU;
- Severe sepsis of septic shock (2001 International Sepsis Definition Conference);
- Age \> 18 years;
- Patient consent.
You may not qualify if:
- Preexisting neuromuscular disorders;
- Recent cardiac or thoracic surgery;
- Use of neuromuscular blocking agent within the 24h preceding the first diaphragm assessment;
- Known preexisting diaphragmatic disorders;
- Cervical spine injury;
- Refusal to participate.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Groupe Hospitalier Paris Saint-Joseph
Paris, Île-de-France Region, 75014, France
Related Publications (7)
Jung B, Nougaret S, Conseil M, Coisel Y, Futier E, Chanques G, Molinari N, Lacampagne A, Matecki S, Jaber S. Sepsis is associated with a preferential diaphragmatic atrophy: a critically ill patient study using tridimensional computed tomography. Anesthesiology. 2014 May;120(5):1182-91. doi: 10.1097/ALN.0000000000000201.
PMID: 24608360BACKGROUNDSupinski GS, Callahan LA. Diaphragm weakness in mechanically ventilated critically ill patients. Crit Care. 2013 Jun 20;17(3):R120. doi: 10.1186/cc12792.
PMID: 23786764BACKGROUNDDemoule A, Jung B, Prodanovic H, Molinari N, Chanques G, Coirault C, Matecki S, Duguet A, Similowski T, Jaber S. Diaphragm dysfunction on admission to the intensive care unit. Prevalence, risk factors, and prognostic impact-a prospective study. Am J Respir Crit Care Med. 2013 Jul 15;188(2):213-9. doi: 10.1164/rccm.201209-1668OC.
PMID: 23641946BACKGROUNDSantos PD, Teixeira C, Savi A, Maccari JG, Neres FS, Machado AS, de Oliveira RP, Ribeiro M, Rotta FT. The critical illness polyneuropathy in septic patients with prolonged weaning from mechanical ventilation: is the diaphragm also affected? A pilot study. Respir Care. 2012 Oct;57(10):1594-601. doi: 10.4187/respcare.01396. Epub 2012 Mar 13.
PMID: 22417531BACKGROUNDBouhemad B, Zhang M, Lu Q, Rouby JJ. Clinical review: Bedside lung ultrasound in critical care practice. Crit Care. 2007;11(1):205. doi: 10.1186/cc5668.
PMID: 17316468BACKGROUNDMatamis D, Soilemezi E, Tsagourias M, Akoumianaki E, Dimassi S, Boroli F, Richard JC, Brochard L. Sonographic evaluation of the diaphragm in critically ill patients. Technique and clinical applications. Intensive Care Med. 2013 May;39(5):801-10. doi: 10.1007/s00134-013-2823-1. Epub 2013 Jan 24.
PMID: 23344830BACKGROUNDSummerhill EM, El-Sameed YA, Glidden TJ, McCool FD. Monitoring recovery from diaphragm paralysis with ultrasound. Chest. 2008 Mar;133(3):737-43. doi: 10.1378/chest.07-2200. Epub 2008 Jan 15.
PMID: 18198248BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aymeric Le Neindre, PT, MSc
Fondation Hôpital Saint-Joseph
- PRINCIPAL INVESTIGATOR
François Philippart, MD, PhD
Fondation Hôpital Saint-Joseph
- PRINCIPAL INVESTIGATOR
Benoît Misset, MD, PhD
Fondation Hôpital Saint-Joseph
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 3, 2015
First Posted
June 18, 2015
Study Start
May 4, 2015
Primary Completion
July 8, 2019
Study Completion
April 1, 2020
Last Updated
May 1, 2020
Record last verified: 2020-04